The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

No­vo Nordisk bud­gets $4.1B for new US man­u­fac­tur­ing site as it aban­dons plans for Irish build

Last year

FDA ships two Form 483s to Dr. Red­dy’s for two sep­a­rate sites in In­dia

Last year
FDA+

US, EU pledge $2B+ to help boost vac­cine man­u­fac­tur­ing in Africa

Last year

Take­da bud­gets $230M for plas­ma ther­a­py fa­cil­i­ty ex­pan­sion in Cal­i­for­nia

Last year

An­oth­er fire breaks out at a No­vo Nordisk site; Ther­mo Fish­er ear­marks $58M in­to a new lab

Last year

Cor­rect­ed: Emer­gent sells Bal­ti­more fa­cil­i­ty for $30M

Last year
Pharma

Sam­sung Bio and Bax­ter di­al up man­u­fac­tur­ing deal to $223M

Last year
Deals

Hik­ma to take over sev­er­al as­sets from Xel­lia, in­clud­ing a US man­u­fac­tur­ing site

Last year
Deals

J&J ce­ments foot­print in Italy with €580M in in­vest­ments over the next 5 years

Last year
R&D
Pharma

Alchem faces fines over price-fix­ing al­le­ga­tion from the Eu­ro­pean Com­mis­sion

Last year
Pharma

Ra­dio­phar­ma ex­ecs warn that lutetium could be at risk of short­age 

Last year

Siegfried nabs US site from Cu­ria; Mer­ck KGaA pumps €62M more in­to its head­quar­ters

Last year

Cor­rect­ed: Life sci­ence com­pa­ny Ag­i­lent cuts over 180+ em­ploy­ees in Cal­i­for­nia 

Last year
People

Ky­owa Kirin in­vests $530M in first man­u­fac­tur­ing site in North Amer­i­ca

Last year
R&D

Mer­ck KGaA’s South Ko­re­an part­ner­ship; Sanofi’s sup­ply chain al­liance with DHL

Last year

Ger­man ra­dio­phar­ma nabs €188M to boost iso­tope man­u­fac­tur­ing, ad­vance can­cer pipeline

Last year
Financing

FDA hands Chi­nese drug man­u­fac­tur­er a Form 483 not­ing em­ploy­ees de­stroyed doc­u­ments 

Last year
China
FDA+

AI is un­like­ly to take off among CD­MOs at the same scale as bio­phar­ma com­pa­nies, in­sid­ers say

Last year
AI

Rayze­Bio warned of po­ten­tial iso­tope sup­ply is­sues be­fore BMS deal

Last year
R&D

Ex­clu­sive: Iso­tope short­age forces pause of Bris­tol My­ers Phase 3 ra­dio­phar­ma­ceu­ti­cal tri­al

Last year
R&D
Pharma

Adap­ti­m­mune taps Gala­pa­gos to de­cen­tral­ize man­u­fac­tur­ing of sol­id tu­mor T cell ther­a­py

Last year
Deals
Cell/Gene Tx

FDA to be­gin re­struc­tur­ing its in­spec­tion of­fice in Oc­to­ber

Last year
FDA+

Al­mac’s 2023 rev­enue bump; France to in­vest in eas­ing green­house gas im­pact

Last year

Ori Biotech, Cy­ti­va sep­a­rate­ly un­veil tech to ac­cel­er­ate cell ther­a­py pro­duc­tion

Last year
Cell/Gene Tx
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times